Jelic Sanja, Padeletti Margherita, Kawut Steven M, Higgins Christopher, Canfield Stephen M, Onat Duygu, Colombo Paolo C, Basner Robert C, Factor Phillip, LeJemtel Thierry H
Columbia University College of Physicians and Surgeons, Division of Pulmonary, Allergy, and Critical Care Medicine, PH8 Center, Room 840, 630 W 168th St, New York, NY 10032, USA.
Circulation. 2008 Apr 29;117(17):2270-8. doi: 10.1161/CIRCULATIONAHA.107.741512. Epub 2008 Apr 14.
Indirect evidence implicates endothelial dysfunction in the pathogenesis of vascular diseases associated with obstructive sleep apnea (OSA). We investigated directly whether dysfunction and inflammation occur in vivo in the vascular endothelium of patients with OSA. The effects of continuous positive airway pressure (CPAP) therapy on endothelial function and repair capacity were assessed.
Thirty-two patients with newly diagnosed OSA and 15 control subjects were studied. Proteins that regulate basal endothelial nitric oxide (NO) production (endothelial NO synthase [eNOS] and phosphorylated eNOS) and inflammation (cyclooxygenase-2 and inducible NOS) and markers of oxidative stress (nitrotyrosine) were quantified by immunofluorescence in freshly harvested venous endothelial cells before and after 4 weeks of CPAP therapy. Vascular reactivity was measured by flow-mediated dilation. Circulating endothelial progenitor cell levels were quantified to assess endothelial repair capacity. Baseline endothelial expression of eNOS and phosphorylated eNOS was reduced by 59% and 94%, respectively, in patients with OSA compared with control subjects. Expression of both nitrotyrosine and cyclooxygenase-2 was 5-fold greater in patients with OSA than in control subjects, whereas inducible NOS expression was 56% greater. Expression of eNOS and phosphorylated eNOS significantly increased, whereas expression of nitrotyrosine, cyclooxygenase-2, and inducible NOS significantly decreased in patients who adhered to CPAP > or = 4 hours daily. Baseline flow-mediated dilation and endothelial progenitor cell levels were lower in patients than in control subjects, and both significantly increased in patients who adhered to CPAP > or = 4 hours daily.
OSA directly affects the vascular endothelium by promoting inflammation and oxidative stress while decreasing NO availability and repair capacity. Effective CPAP therapy is associated with the reversal of these alterations.
间接证据表明内皮功能障碍与阻塞性睡眠呼吸暂停(OSA)相关的血管疾病发病机制有关。我们直接研究了OSA患者血管内皮在体内是否存在功能障碍和炎症。评估了持续气道正压通气(CPAP)治疗对内皮功能和修复能力的影响。
研究了32例新诊断的OSA患者和15例对照受试者。在CPAP治疗4周前后,通过免疫荧光对新鲜采集的静脉内皮细胞中调节基础内皮一氧化氮(NO)生成的蛋白质(内皮型一氧化氮合酶[eNOS]和磷酸化eNOS)、炎症相关蛋白(环氧化酶-2和诱导型一氧化氮合酶)以及氧化应激标志物(硝基酪氨酸)进行定量分析。通过血流介导的血管舒张来测量血管反应性。对循环内皮祖细胞水平进行定量分析以评估内皮修复能力。与对照受试者相比,OSA患者中eNOS和磷酸化eNOS的基线内皮表达分别降低了59%和94%。OSA患者中硝基酪氨酸和环氧化酶-2的表达均比对照受试者高5倍,而诱导型一氧化氮合酶表达高56%。每日坚持使用CPAP≥4小时的患者中,eNOS和磷酸化eNOS的表达显著增加,而硝基酪氨酸、环氧化酶-2和诱导型一氧化氮合酶的表达显著降低。患者的基线血流介导的血管舒张和内皮祖细胞水平低于对照受试者,而每日坚持使用CPAP≥4小时的患者中这两者均显著增加。
OSA通过促进炎症和氧化应激,同时降低NO可用性和修复能力,直接影响血管内皮。有效的CPAP治疗与这些改变的逆转相关。